Reduction of cell proliferation induced by PD166866: An inhibitor of the basic fibroblast growth factor

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 3, 2007, Pages 405-409

  Calandrella, N ^a   Risuleo, Gianfranco ^a   Scarsella, G ^a   Mustazza, C ^b   Castelli, M ^c   Galati, F ^a   Giuliani, A ^a   Galati, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell death; Fibroblast growth factor; Reduction of cell proliferation

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLINE; PD 166866; PROTEIN TYROSINE KINASE INHIBITOR; PYRIDO[2,3]PYRIMIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; MICE; PROLIFERATING CELL NUCLEAR ANTIGEN; PYRIMIDINES; UREA;

EID: 35348877142     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Plotnikov A.N., Hubbard S.R., Chlessinger J. and Mohammadi M.: Cristal structures of two FGF- FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101, 413-424, 2000.
2. Zhu X., Komiya H., Chirino A., Faham S., Fox G.M., Arakawa T., Hsu B.T. and Rees D.C.: Three-dimensional structures of acid and basic fibroblast growth factors. Science 251, 90-93, 1991.
3. Eriksson A.E., Cousens L.S., Weaver L.H. and Matthews B.W.: Trhee-dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88, 3441-3445, 1991.
4. Wright J.A. and Huang A.: Growth factors in mechanisms of malignancy: roles for TGF-β and FGF. Histol. Histopathol. 11, 521-536, 1996.
5. Stumm G., Eberwein S., Rostock-Wolf S., Stein H., Pomer S., Schlegel J. and Waldherr R.: Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int. J. Cancer. 69, 17-22. 1996.
6. Davies D.E. and Chamberlin S.G.: Targeting the epidermal growth factor receptor for therapy of carcinomas. Biochem. Pharmacol. 51, 1101-1110, 1996.
7. Desmouliere A., Christelle G. and Gabbiani G.: The stroma reaction myofibroblast: a key player in the control of tumor cell behaviour. Int. J. Dev. Biol. 48, 509-517, 2004.
8. De Wever O. and Mareel M.: Role of tissue stroma in cancer cell invasion. J. Pathol. 200, 429-447, 2003.
9. Seemayer T.A., Lagace R., Schurch W. and Tremblay G.: Myofibroblasts in the stroma of invasive and metastatic carcinoma: a possible host response to neoplasia. Am. J. Surg. Pathol. 3, 525-533, 1979.
10. Dvorak H.F.: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659, 1986.
11. Desmoulière A. and Gabbiani G.: The role of the myofibroblast in wound healing and fibrocontractive diseases. In The Molecular and Cellular Biology of Wound Repair (2nd edition). Clark RAF (ed). Plenum Publishing Corporation, New York, pp 391-423, 1996.
12. Desmoulière A., Darby I.A. and Gabbiani G.: Normal and pathological soft tissue remodeling: role of the myofibroblast. With special emphasis on liver and kidney fibrosis. Lab. Invest. 83, 1689-1707, 2003.
13. Blankley C.J., Boschelli D.H., Doherty A.M., Hamby J.M., Klutchko S. and Panek R.L.: Pyrrido 2,3-d pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation. United States patent No 5, 620, 981, 1997.
14. Panek R.L., Lu G.H., Dahring T.K., Batey B.L., Connolly C., Hamby J. and Brown K.J.: In Vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J. Pharmacol. Exp. Ther. 286, 569-577, 1998.
15. Iacoangeli A., Melucci-Vigo G. and Risuleo G.: Mechanism of the inhibition of murine Polyomavirus DNA replication induced by the ionophore monensin. Biochimie 82, 35-39, 2000.
16. Campanella L., Delfini M., Ercole P., Iacoangeli A. and Risuleo G.: Molecular characterization and action of usnic Acid: a drug that inhibits proliferation of mouse Polyomavirus in vitro and its main target is RNA transcription. Biochimie. 84, 329-334, 2002.
17. Pillich R.T., Scarsella G., Galati G., Izzo L., Iacoangeli A., Castelli M., Risuleo G.: The diimide drug PIPER has a cytotoxic dose-dependent effect in vitro and inhibits telomere elongation in HELA cells. Anticancer Res. 25, 3341-33466, 2005.
18. Di Ilio V., Pasquariello N., van der Esch S.A., Cristofaro M., Scarsella G., Risuleo G.: Cytotoxic and antiproliferative effects induced by a non terpenoid polar extract of A. indica seeds on 3T6 murine fibroblasts in culture. Molec. Cell. Biochem., 287, 69-77, 2006.
19. Calandrella N., Scarsella G., Pescosolido N., Risuleo G.: Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension, Mol. Cell. Biochem. 301(1-2): 155-163, 2007.
20. Hamby J.M., Connolly C.J.C., Schroeder M.C., Winters R.T., Showalter H.D.H., Panek R.L., Major T.C., Olsewski B., Ryan M.J., Dahring T., Lu G.H., Keiser J., Amar A., Shen C., Kraker A.J., Slintak V., Nelson J.M., Fry D.W., Bradford L., Hallak H., Doherty A.: Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors, J. Med. Chem., 40, 2296-2303, 1997.
21. Mosmann T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55-63, 1983.
22. SPSS Statistical Procedures of the Social Sciences, SPSS-X user's guide, 6th ed. SPSS Inc., Chicago, 1993.